Art

J-GLOBAL ID：201002288862812707   Reference number：10A0776896

Successful Outcomes Using Combination Therapy of Interleukin-2 and Interferon-α for Renal Cell Carcinoma Patients with Lung Metastasis

肺転移のある腎細胞癌患者に対するインターロイキン-2とインタフェロン-αの併用療法による良好な転帰

Author (11)： AKAZA Hideyuki (Univ. Tsukuba, Ibaragi) ,  KAWAI Koji (Univ. Tsukuba, Ibaragi) ,  TSUKAMOTO Taiji (Sapporo Medical Univ. School of Medicine, Sapporo) ,  FUJIOKA Tomoaki (Iwate Medical Univ. School of Medicine, Iwate) ,  TOMITA Yoshihiko (Yamagata Univ., Yamagata) ,  KITAMURA Tadaichi (Univ. Tokyo, Tokyo) ,  OZONO Seiichiro (Hamamatsu Univ. School of Medicine, Shizuoka) ,  MIKI Tsuneharu (Kyoto Prefectural Univ. Medicine, Kyoto) ,  NAITO Seiji (Kyushu Univ., Fukuoka) ,  ZEMBUTSU Hitoshi (Univ. Tokyo, JPN) ,  NAKAMURA Yusuke (Univ. Tokyo, JPN)
Material： Japanese Journal of Clinical Oncology  (JJCO)
Volume： 40  Issue： 7  Page： 684-689  Publication year： Jul. 2010 
JST Material Number： W2222A  ISSN： 0368-2811  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： Lung metastases

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=10A0776896&from=J-GLOBAL&jstjournalNo=W2222A") }}

JST classification (3)： Urogenital tumors(=neoplasms)  (GM04000S) ,  Tumors(=neoplasms)of respiratory system  (GI04000G) ,  Treatment for tumors in general  (GE03031L)

Reference (25)：

• Vogelzang NJ, Priest ER, Borden L. Spontaneous regression of histologically proved pulmonary metastases from renal cell carcinoma: a case with 5-year followup. J Urol 1992; 148: 1247-8.
• Motzer RJ, Russo P. Systemic therapy for renal cell carcinoma. J Urol 2000; 163: 408-17.
• Klapper JA, Downey SG, Smith FO, Yang JC, Hughes MS, Kammula US, et al. High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma: a retrospective analysis of response and survival in patients treated in the Surgery Branch at the National Cancer Institute between 1986 and 2006. Cancer 2008; 113: 293-301.
• Belldegrun AS, Klatte T, Shuch B, LaRochelle JC, Miller DC, Said JW, et al. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies. Cancer 2008; 113: 2457-63.
• Aso Y, Tazaki H, Umeda T, Marumo K. A phase II study of S-6820 (recombinant interleukin-2) on renal cell carcinoma. Biotherapy 1989; 3: 999-1007 (in Japanese).

Terms in the title (7)： 肺転移 ,  腎細胞 ,  癌患者 ,  インターロイキン-2 ,  インタフェロン ,  併用療法 ,  転帰